Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Krantz

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|August 26, 2017
Recurrence of extreme serum analytes in consecutive pregnancies and association with obstetrical outcomes<sup></sup>Shelly Soni, David A Krantz, Meir Greenberg, et al.
Obstetrics and Gynecology|September 23, 2010
Undermeasurement of nuchal translucencies: implications for screeningMark I Evans, David A Krantz, Terrence W Hallahan, et al.
Clinical Chemistry|January 5, 2006
First-trimester Down syndrome screeningTerrence W Hallahan, David A Krantz, V James Macri, et al.
Prenatal Diagnosis|July 29, 2005
Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening programDavid A Krantz, Terrence W Hallahan, V James Macri, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|April 13, 2018
Elevated maternal serum-free β-human chorionic gonadotropin (β-hCG) and reduced risk of spontaneous preterm delivery<sup></sup>Shelly Soni, David A Krantz, Matthew J Blitz, et al.
American Journal of Obstetrics and Gynecology|March 10, 2007
Meta-analysis of first trimester Down syndrome screening studies: free beta-human chorionic gonadotropin significantly outperforms intact human chorionic gonadotropin in a multimarker protocolMark I Evans, David A Krantz, Terrence W Hallahan, et al.
Fetal Diagnosis and Therapy|April 4, 2013
Quality of nuchal translucency measurements correlates with broader aspects of program rigor and culture of excellenceMark I Evans, David A Krantz, Terrence Hallahan, et al.
American Journal of Obstetrics and Gynecology|November 16, 2011
First-trimester screening in tripletsDavid A Krantz, Terrence W Hallahan, Kuanglin He, et al.
American Journal of Obstetrics and Gynecology|March 14, 2003
Combined first-trimester versus second-trimester serum screening for Down syndrome: a cost analysisWilliam Cusick, Philip Buchanan, Terrence W Hallahan, et al.
Prenatal Diagnosis|June 15, 2017
Expanded conventional first trimester screeningJonathan B Carmichael, Hsiao-Pin Liu, David Janik, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|August 26, 2017
Recurrence of extreme serum analytes in consecutive pregnancies and association with obstetrical outcomes<sup></sup>Shelly Soni, David A Krantz, Meir Greenberg, et al.
Obstetrics and Gynecology|September 23, 2010
Undermeasurement of nuchal translucencies: implications for screeningMark I Evans, David A Krantz, Terrence W Hallahan, et al.
Clinical Chemistry|January 5, 2006
First-trimester Down syndrome screeningTerrence W Hallahan, David A Krantz, V James Macri, et al.
Prenatal Diagnosis|July 29, 2005
Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening programDavid A Krantz, Terrence W Hallahan, V James Macri, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|April 13, 2018
Elevated maternal serum-free β-human chorionic gonadotropin (β-hCG) and reduced risk of spontaneous preterm delivery<sup></sup>Shelly Soni, David A Krantz, Matthew J Blitz, et al.
American Journal of Obstetrics and Gynecology|March 10, 2007
Meta-analysis of first trimester Down syndrome screening studies: free beta-human chorionic gonadotropin significantly outperforms intact human chorionic gonadotropin in a multimarker protocolMark I Evans, David A Krantz, Terrence W Hallahan, et al.
Fetal Diagnosis and Therapy|April 4, 2013
Quality of nuchal translucency measurements correlates with broader aspects of program rigor and culture of excellenceMark I Evans, David A Krantz, Terrence Hallahan, et al.
American Journal of Obstetrics and Gynecology|November 16, 2011
First-trimester screening in tripletsDavid A Krantz, Terrence W Hallahan, Kuanglin He, et al.
American Journal of Obstetrics and Gynecology|March 14, 2003
Combined first-trimester versus second-trimester serum screening for Down syndrome: a cost analysisWilliam Cusick, Philip Buchanan, Terrence W Hallahan, et al.
Prenatal Diagnosis|June 15, 2017
Expanded conventional first trimester screeningJonathan B Carmichael, Hsiao-Pin Liu, David Janik, et al.
Pageof 3